BRAF: A New Target to Treat in Lung Cancer episode artwork

EPISODE · Jul 16, 2015 · 4 MIN

BRAF: A New Target to Treat in Lung Cancer

from GRACEcast · host cancerGRACE Meetings

A study released at ASCO 2015 showed that the BRAF V600E mutation had a high response rate to combination therapy Tafinlar (dabrafenib) plus Mekinist (trametinib), which led the doctors to agree that BRAF testing in lung cancer should become commonplace.

Episode metadata supplied by the publisher feed · Published Jul 16, 2015

Embed this episode

NOW PLAYING

BRAF: A New Target to Treat in Lung Cancer

0:00 4:19

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of GRACEcast?

This episode is 4 minutes long.

When was this GRACEcast episode published?

This episode was published on July 16, 2015.

Can I download this GRACEcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!